Home › Funds › Decheng Capital LLC › AARD

Decheng Capital LLC position in AARD

AARDVARK THERAPEUTICS INC · Health Care

Decheng Capital LLC reported holding 3,917,299 shares of AARD (AARDVARK THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$20.6M, representing 3.01% of its reported portfolio and ranking #4 among its reported holdings. Decheng Capital LLC has disclosed AARD holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)3.92M sh
Reported value held$20.64M
Portfolio Weight3.01%
First reportedQ1 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Decheng Capital LLC's AARD position evolved

Decheng Capital LLC first disclosed a stake in AARD in Q1 2025 at 3,917,299 shares (US$29.4M). The position peaked in Q2 2025 at 3,917,299 shares, worth US$53.0M. Across 7 filings, Decheng Capital LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,917,299 shares valued at US$20.6M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 3.92M $29.42M New
Q2 2025 3.92M $52.96M Hold
Q3 2025 3.92M $52.06M Hold
Q4 2025 3.92M $51.41M Hold
Q1 2026 3.92M $14.77M Hold
Q2 2026 3.92M $22.56M Hold
Q3 2026 3.92M $20.64M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AARD and 13F data

AARD (AARDVARK THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in AARD — the largest reported positions include EcoR1 Capital, LLC (US$85K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AARD

All AARD fund holders →

FAQ

How long has Decheng Capital LLC held AARD?

Decheng Capital LLC has disclosed AARD holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Decheng Capital LLC's current position in AARD?

As of Q3 2026, Decheng Capital LLC holds 3.92M shares of AARD (AARDVARK THERAPEUTICS INC), valued at $20.64M, representing 3.01% of its reported portfolio and ranking #4.

Has Decheng Capital LLC been buying or selling AARD?

In the latest 13F filing (Q3 2026), Decheng Capital LLC held unchanged its position in AARD. The position peaked in Q2 2025 at 3.92M shares.

Which other funds hold AARD?

Other major institutional holders of AARD include EcoR1 Capital, LLC, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.